Ascend Wellness Holdings, Inc. (AAWH)
(Delayed Data from OTC)
$1.07 USD
-0.02 (-1.38%)
Updated Aug 2, 2024 03:59 PM ET
4-Sell of 5 4
A Value A Growth F Momentum A VGM
Income Statements
Fiscal Year end for Ascend Wellness Holdings, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 519 | 406 | 332 | 144 | 12 |
Cost Of Goods | 363 | 271 | 196 | 83 | 9 |
Gross Profit | 155 | 135 | 136 | 61 | 3 |
Selling & Adminstrative & Depr. & Amort Expenses | 159 | 142 | 153 | 53 | 29 |
Income After Depreciation & Amortization | -4 | -8 | -17 | 8 | -26 |
Non-Operating Income | 26 | 1 | 0 | 0 | 0 |
Interest Expense | 37 | 32 | 64 | 13 | 6 |
Pretax Income | -15 | -39 | -81 | -5 | -33 |
Income Taxes | 33 | 42 | 42 | 19 | 1 |
Minority Interest | 0 | 0 | 0 | 2 | -1 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -48 | -81 | -123 | -24 | -33 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -48 | -81 | -123 | -25 | -32 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 56 | 31 | 6 | 21 | -22 |
Depreciation & Amortization (Cash Flow) | 60 | 38 | 24 | 13 | 4 |
Income After Depreciation & Amortization | -4 | -8 | -17 | 8 | -26 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 199.15 | 183.38 | 149.43 | NA | NA |
Diluted EPS Before Non-Recurring Items | -0.24 | -0.44 | -0.58 | NA | NA |
Diluted Net EPS (GAAP) | -0.24 | -0.44 | -0.82 | -0.27 | NA |
Fiscal Year end for Ascend Wellness Holdings, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 142.41 | 140.16 | 141.27 | 122.99 |
Cost Of Goods | NA | 90.37 | 92.62 | 97.71 | 94.67 |
Gross Profit | NA | 52.04 | 47.54 | 43.56 | 28.32 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 49.46 | 46.98 | 40.01 | 36.30 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 2.58 | 0.56 | 3.55 | -7.98 |
Non-Operating Income | NA | 0.31 | 0.63 | 0.90 | 24.04 |
Interest Expense | NA | 8.54 | 8.57 | 8.96 | 10.48 |
Pretax Income | NA | -5.65 | -7.37 | -4.51 | 5.58 |
Income Taxes | NA | 12.51 | 11.97 | 6.73 | 4.74 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -18.16 | -19.34 | -11.24 | 0.84 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -18.16 | -19.34 | -11.24 | 0.84 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 208.95 | 206.61 | 205.71 | 195.65 |
Diluted EPS Before Non-Recurring Items | NA | -0.09 | -0.09 | -0.05 | 0.00 |
Diluted Net EPS (GAAP) | NA | -0.09 | -0.09 | -0.05 | 0.00 |